Radiology, Vol 203, 339-341, Copyright © 1997 by Radiological Society of North America

ARTICLES

Screening mammography: sensitivity and specificity in relation to hormone replacement therapy

EL Thurfjell, LH Holmberg and IR Persson
Department of Diagnostic Radiology, University Hospital, Uppsala, Sweden.

PURPOSE: To evaluate the possible effects of hormone replacement therapy (HRT) on the sensitivity and specificity of screening mammography. MATERIALS AND METHODS: Twenty thousand women aged 50 years or older were interviewed about use of HRT during the second round of screening mammography; of these, 3,126 were currently using, 2,158 had previously used, and 14,716 had never used HRT. Women with breasts known to be composed of predominantly fatty tissue were examined with one-view mammography; otherwise, two-view mammography was used. RESULTS: The sensitivity of screening mammography was 96% (95% confidence interval, 81.0%, 99.1%) in women currently using, 92% (61.5%, 99.8%) in women who had previously used, and 91% (85.7%, 96.8%) in women who had never used HRT. The specificity was 94% (93.3%, 95.0%), 95% (93.7%, 95.6%), and 95% (94.8%, 95.5%), respectively. There was a slight decrease in specificity with duration of treatment for the current-user group. However, specificity in women treated with continuous combined estradiol-progestin for less than 3 years (90%) was lower than that in women treated with other regimens (95%, P = .037). CONCLUSION: There was no decrease in the sensitivity of screening mammography in women currently using HRT, but there was a marginal decrease in specificity varying with the HRT regimen and duration of treatment.

This article has been cited by other articles:

				A. M. Kavanagh, G. B. Byrnes, C. Nickson, J. N. Cawson, G. G. Giles, J. L. Hopper, D. M. Gertig, and D. R. English Using Mammographic Density to Improve Breast Cancer Screening Outcomes Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2818 - 2824. [Abstract] [Full Text] [PDF]

				P. A. Carney, D. L. Miglioretti, B. C. Yankaskas, K. Kerlikowske, R. Rosenberg, C. M. Rutter, B. M. Geller, L. A. Abraham, S. H. Taplin, M. Dignan, et al. Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography Ann Intern Med, February 4, 2003; 138(3): 168 - 175. [Abstract] [Full Text] [PDF]

				W. E. Barlow, C. D. Lehman, Y. Zheng, R. Ballard-Barbash, B. C. Yankaskas, G. R. Cutter, P. A. Carney, B. M. Geller, R. Rosenberg, K. Kerlikowske, et al. Performance of Diagnostic Mammography for Women With Signs or Symptoms of Breast Cancer J Natl Cancer Inst, August 7, 2002; 94(15): 1151 - 1159. [Abstract] [Full Text] [PDF]

				J. Fiorica, C. M. Rutter, M. T. Mandelson, S. Taplin, and M. B. Laya Association Between Changes in Hormone Replacement Therapy and Breast Density JAMA, April 11, 2001; 285(14): 1839 - 1840. [Full Text] [PDF]

				C. M. Thomas, M. A. Roubidoux, T. E. Wilson, R. J. Orange, J. T. Fitzgerald, M. A. Helvie, and S. A. Packer Assessing the Effect of Hormone Replacement Therapy on the Performance of Screening Mammography • Dr Roubidoux and colleagues respond: Radiology, December 1, 1999; 213(3): 926 - 927. [Full Text]

				C. J. Baines and R. Dayan A Tangled Web: Factors Likely to Affect the Efficacy of Screening Mammography J Natl Cancer Inst, May 19, 1999; 91(10): 833 - 838. [Full Text] [PDF]